Transdermal Delivery of Antihypertensive Agents: A tabular update

Jain, Ashish; Mishra, Anurag; Nayak, Satish; Soni, Vandana
April 2011
International Journal of Drug Delivery;Apr2011, p1
Academic Journal
Transdermal Drug Delivery System is viable drug delivery platform technology and has a strong market world wide. Transdermal Drug Delivery System is particularly desirable for drugs that need prolonged administration at controlled plasma level that basis make appropriateness to antihypertensive agents for their transdermal development. Controlled zero order absorption, easily termination of drug delivery, easy to administration also support for popularity of transdermal delivery. This paper reviews the work on transdermal studies of antihypertensive agents in the tabular form.


Related Articles

  • FORMULATION AND EVALUATION ASPECTS OF TRANSDERMAL DRUG DELIVERY SYSTEM. Patel, Dipen M.; Kavitha, K. // International Journal of Pharmaceutical Sciences Review & Resear;Jan/Feb2011, Vol. 6 Issue 2, p83 

    The conventional oral dosage forms has significant drawbacks of poor bioavailability due to hepatic first pass metabolism and tendency to produce rapid blood level spikes (Both high and low), leading to a need for high and/or frequent dosing, which can be both cost prohibitive and inconvenient....

  • Drug Dispensers. Perros, George // Paper, Film & Foil Converter;Oct2003, Vol. 77 Issue 10, p49 

    Discusses the opportunities offered by transdermal patches for companies that manufacture drug patches and their supply chain partners. Components of transdermal delivery system; Major market driver for the over-the-counter patch; Types of transdermal delivery system products; Emerging and...

  • Developing Custom Adhesive Systems for Transdermal Drug Delivery Products. Hopp, Melinda S. // Pharmaceutical Technology North America;Mar2002, Vol. 26 Issue 3, p30 

    Looks into the market acceptance on the development of adhesive systems for transdermal drug delivery systems in the U.S. Methods of drug administration; Delivery of materials like nicotine for smoking cessation; Challenges for specialty adhesives manufacturers.

  • Product News.  // Nurse Prescribing;Jan2013, Vol. 11 Issue 1, p50 

    No abstract available.

  • Transdermal Patch Drug Delivery Interactions with Exercise. Lenz, Thomas L.; Gillespie, Nicole // Sports Medicine;2011, Vol. 41 Issue 3, p177 

    Transdermal drug delivery systems, such as the transdermal patch, continue to be a popular and convenient way to administer medications. There are currently several medications that use a transdermal patch drug delivery system. This article describes the potential untoward side effects of...

  • Deproteinised natural rubber used as a controlling layer membrane in reservoir-type nicotine transdermal patches. Pichayakorn, Wiwat; Suksaeree, Jirapornchai; Boonme, Prapaporn; Taweepreda, Wirach; Amnuaikit, Thanaporn; Ritthidej, Garnpimol C. // Chemical Engineering Research & Design: Transactions of the Inst;Mar2013, Vol. 91 Issue 3, p520 

    Reservoir-type nicotine transdermal patches (NTPs), composed of a concentrated nicotine solution embedded between a backing layer and a controlling layer membrane, were constructed by a heat-sealing technique. The aim of this research was the preparation of a novel controlling layer membrane...

  • Real-Time UV Imaging of Nicotine Release from Transdermal Patch. Østergaard, Jesper; Meng-Lund, Emil; Larsen, Susan; Larsen, Claus; Petersson, Karsten; Lenke, James; Jensen, Henrik // Pharmaceutical Research;Dec2010, Vol. 27 Issue 12, p2614 

    Purpose: This study was conducted to characterize UV imaging as a platform for performing in vitro release studies using Nicorette® nicotine patches as a model drug delivery system. Methods: The rate of nicotine release from 2 mm diameter patch samples (Nicorette®) into 0.067 M phosphate...

  • Transdermal Drug Formulation. Peterson, Timothy A. // Pharmaceutical Technology;Jun2003 Supplement, Vol. 27 Issue 6, p18 

    Discusses the process development of transdermal drug formulation. Transdermal system design; Assessment of technical compatibility of a drug with transdermal drug delivery technology; Skin permeation rate; Packaging of the transdermal product.

  • Transdermal Drug Delivery of Labetolol Hydrochloride: System Development, In Vitro; Ex Vivo and In Vivo Characterization. Aqil, M.; Zafar, Saqib; Ali, Asgar; Ahmad, Shoaib // Current Drug Delivery;Jun2005, Vol. 2 Issue 2, p125 

    OBJECTIVE. The aim of the present work was to develop and evaluate matrix type transdermal drug delivery systems (TDDS) of labetolol hydrochloride (L-HCL) effective for 48 hours. EXPERIMENTAL. The TDDS were prepared by solvent evaporation technique. Six formulations (carrying Eudragit...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics